The move brings the company's coverage to 95% of the state.

According to the companies, more than 100 patients use the target's products to help make health care decisions.

The new location serves the needs of companies developing and commercializing radiopharmaceuticals, from preclinical and early-stage clinical trials to full scale commercial production of approved products.

Last week, an FDA advisory panel backed a second Johnson & Johnson dose for adults who received the first two months ago, and for certain adults who got the second Moderna inoculation at least six months ago.

Ten businesses nabbed licenses to grow and four received vertically integrated ones allowing them to grow, process, manufacture and sell cannabis flower and products to the state's more than 18,800 medical patients and, eventually, adult use customers.

Pared down directives still advocate strongly for face coverings, staying outdoors and getting the COVID shot as a means to minimize risk and keep your family and friends safer.

Valley Health System has been invited to participate in a nationwide pilot project designed to increase racial and ethnic diversity in cancer clinical trial participants.

Patients in Central New Jersey with early-stage breast cancer may benefit from accessing a treatment that does not require traditional invasive surgery: Cryoablation uses a small needle and the cooling power of liquid nitrogen to freeze and destroy tumors.

At the beginning of October, Rutgers Cancer Institute of New Jersey at University Hospital in Newark held its fifth annual See, Test & Treat event where members of the community could receive free screenings for several types of cancer all in one day.

The 12-story, 510,000-square-foot Jack & Sheryl Morris Cancer Center in New Brunswick will be a state-of-the-art facility featuring outpatient and inpatient capacity coupled with research laboratories, retail space and ancillary services devoted to patient wellness.

If all goes according to plan, a brand new, state of the art research and technology facility will occupy an empty parcel in the center of downtown in a few years after state and city officials broke ground on the $665 million, 550,000-square-foot New Jersey Innovation and Technology Hub on Oct. 14.

Among other measures, a $2 billion trust will be established to facilitate an efficient resolution of claims.